Loading...
Header Logo
Keywords
Last Name
KP Region

Karen Wernli, PhD

TitleAssociate Investigator
InstitutionKaiser Permanente Washington
DepartmentHealth Research Institute
ORCID ORCID Icon0000-0001-7945-0327 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Karen Wernli, PhD, is a cancer epidemiologist and health services research whose research focuses incorporating patient centered outcomes for on improving cancer care from diagnosis to survivorship. Her works spans many types of cancer, including breast, colorectal, lung, and ovarian.

    Dr. Wernli leads a Patient-Centered Outcomes Research Institute (PCORI) project that compared breast MRI (magnetic resonance imaging) to mammography for women already treated for breast cancer. Called SIMBA (Surveillance Imaging Modalities for Breast Cancer Assessment), the 3-year study used data from the Breast Cancer Surveillance Consortium (BCSC) and engaged patients and stakeholders to determine the best information for patient and physician decision-making. Dr. Wernli’s team then translated that information into a new decision aid for women who have had breast cancer. PCORI has recognized this work nationally and pointed to SIMBA as a model for effective patient engagement.

    Dr. Wernli’s other breast cancer projects include a National Cancer Institute (NCI)-funded study to examine trends and outcomes related to the mandatory notification of breast density that has been enacted in many states. With colleagues at Georgetown University, she is working on another NCI-funded study that is looking at the best ways to inform women about breast cancer risk and options for managing it.

    In the Clare Project, Dr. Wernli and colleagues at Kaiser Permanente Washington Health Research Institute (KPWHRI) are exploring how adolescent and young adult patients with advanced cancer make medical decisions. The goal is to improve care for young people with advanced-stage cancer by asking them what they need, want, and value.

    Dr. Wernli is a co-investigator of KPWHRI’s Colorectal Cancer Screening Registry, which is part of NCI’s Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) program. Through PROSPR, she leads a study looking at colorectal cancer screening in real-world practice. She is also helping Kaiser Permanente Washington develop more effective colorectal cancer prevention strategies.

    After training at MD Anderson Cancer Center and Fred Hutchinson Cancer Research Center, Dr. Wernli joined KPWHRI in 2009 and began a three-year career development award in comparative effectiveness research (CER) in 2010. In addition to CER, her other areas of expertise include:

    - patient-centered outcomes research,
    - patient and stakeholder engagement,
    - observational study design, and
    - adolescent and young adult populations.

    Dr. Wernli has published more than 75 peer-reviewed manuscripts in leading journals and regularly serves as a grant reviewer for the National Institutes of Health.

    Collapse Research 
    Collapse research activities and funding
    R03CA159080     (WERNLI, KAREN J)Apr 1, 2011 - Mar 31, 2014
    NIH/NCI
    Mammographic Breast Density and Ovarian Cancer
    Role: Principal Investigator

    R21CA205309     (WERNLI, KAREN J)May 9, 2016 - Apr 30, 2018
    NIH/NCI
    National trends in end of life care for adolescent and young adult cancer patients
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE. Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population. J Womens Health (Larchmt). 2018 Nov 27. PMID: 30481098.
      View in: PubMed
    2. Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2018 Nov 20. PMID: 30459208.
      View in: PubMed
    3. Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL. The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume. AJR Am J Roentgenol. 2018 Nov; 211(5):957-963. PMID: 30235000.
      View in: PubMed
    4. Figueroa Gray M, Ludman EJ, Beatty T, Rosenberg AR, Wernli KJ. Balancing Hope and Risk Among Adolescent and Young Adult Cancer Patients with Late-Stage Cancer: A Qualitative Interview Study. J Adolesc Young Adult Oncol. 2018 Aug 10. PMID: 30096254.
      View in: PubMed
    5. Roth JA, Carter-Harris L, Brandzel S, Buist DSM, Wernli KJ. A qualitative study exploring patient motivations for screening for lung cancer. PLoS One. 2018; 13(7):e0196758. PMID: 29975709.
      View in: PubMed
    6. Greene SM, Brandzel S, Wernli KJ. From Principles to Practice: Real-World Patient and Stakeholder Engagement in Breast Cancer Research. Perm J. 2018 06 06; 22. PMID: 29911967.
      View in: PubMed
    7. Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med. 2018 Apr 01; 178(4):458-468. PMID: 29435556.
      View in: PubMed
    8. Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat. 2018 Jul; 170(1):149-157. PMID: 29516372.
      View in: PubMed
    9. Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May; 113(5):746-754. PMID: 29487413.
      View in: PubMed
    10. Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754. PMID: 29341851.
      View in: PubMed
    11. Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 08; 27(8):987-993. PMID: 29334616.
      View in: PubMed
    12. Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T. Utilization of breast cancer screening with magnetic resonance imaging in community practice. J Gen Intern Med. 2018 Mar; 33(3):275-283. PMID: 29214373.
      View in: PubMed
    13. Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015. PMID: 29127715.
      View in: PubMed
    14. Sakoda LC, Henderson LM, Caverly TJ, Wernli KJ, Katki HA. Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions. Curr Epidemiol Rep. 2017 Dec; 4(4):307-320. PMID: 29531893.
      View in: PubMed
    15. Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52. PMID: 28582633.
      View in: PubMed
    16. Carter-Harris L, Brandzel S, Wernli KJ, Roth JA, Buist DSM. A qualitative study exploring why individuals opt out of lung cancer screening. Fam Pract. 2017 04 01; 34(2):239-244. PMID: 28122849.
      View in: PubMed
    17. Sethi R, Buchlak QD, Yanamadala V, Anderson ML, Baldwin EA, Mecklenburg RS, Leveque JC, Edwards AM, Shea M, Ross L, Wernli KJ. A systematic multidisciplinary initiative for reducing the risk of complications in adult scoliosis surgery. J Neurosurg Spine. 2017 Jun; 26(6):744-750. PMID: 28362214.
      View in: PubMed
    18. Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, Quinn VP, Wernli K, Zheng Y, Skinner CS. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar; 96(11):e6326. PMID: 28296752.
      View in: PubMed
    19. Knerr S, Wernli KJ, Leppig K, Ehrlich K, Graham AL, Farrell D, Evans C, Luta G, Schwartz MD, O'Neill SC. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017 05; 56:25-33. PMID: 28257920.
      View in: PubMed
    20. Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 08; 26(8):820-827. PMID: 28177856.
      View in: PubMed
    21. Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ. Women's experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence. 2017; 11:199-204. PMID: 28203064.
      View in: PubMed
    22. Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J. Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud. 2016 Aug; 2:51-64. PMID: 28530002.
      View in: PubMed
    23. Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Reply. Gastroenterology. 2016 09; 151(3):564. PMID: 27496674.
      View in: PubMed
    24. Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016 Jul 26; 316(4):436-47. PMID: 27458949.
      View in: PubMed
    25. Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA. Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Med Care. 2016 07; 54(7):719-24. PMID: 27111752; PMCID: PMC5001851 [Available on 07/01/17].
    26. Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM. Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol. 2017 Jun; 17(2):101-112. PMID: 28943779.
      View in: PubMed
    27. Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson ANA, Wernli KJ, Onega T. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 08; 89:169-177. PMID: 27261409.
      View in: PubMed
    28. Onega T, Tosteson AN, Weiss J, Alford-Teaster J, Hubbard RA, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA. Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. BMC Health Serv Res. 2016 Feb 27; 16:76. PMID: 26920552; PMCID: PMC4769533.
    29. Johnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involv Engagem. 2016; 2:6. PMID: 29062507.
      View in: PubMed
    30. Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan; 206(1):211-6. PMID: 26700354; PMCID: PMC4864981 [Available on 01/01/17].
    31. Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15; 122(4):611-7. PMID: 26709819.
      View in: PubMed
    32. Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks Associated With Anesthesia Services During Colonoscopy. Gastroenterology. 2016 Apr; 150(4):888-94; quiz e18. PMID: 26709032.
      View in: PubMed
    33. Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep; 205(3):676-84. PMID: 26295657; PMCID: PMC4547477.
    34. Wieneke AE, Bowles EJ, Cronkite D, Wernli KJ, Gao H, Carrell D, Buist DS. Validation of natural language processing to extract breast cancer pathology procedures and results. J Pathol Inform. 2015; 6:38. PMID: 26167382; PMCID: PMC4485196.
    35. Gallagher LG, Li W, Ray RM, Romano ME, Wernli KJ, Gao DL, Thomas DB, Checkoway H. Occupational exposures and risk of stomach and esophageal cancers: update of a cohort of female textile workers in Shanghai, China. Am J Ind Med. 2015 Mar; 58(3):267-75. PMID: 25611949.
      View in: PubMed
    36. Li W, Ray RM, Thomas DB, Davis S, Yost M, Breslow N, Gao DL, Fitzgibbons ED, Camp JE, Wong E, Wernli KJ, Checkoway H. Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control. 2015 Jan; 26(1):143-50. PMID: 25421377; PMCID: PMC4323154.
    37. Onega T, Weiss J, Kerlikowske K, Wernli K, Buist DS, Henderson LM, Goodrich M, Alford-Teaster J, Virnig B, Tosteson AN, DeMartini W, Hubbard R. The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy. Springerplus. 2014; 3:416. PMID: 25140292; PMCID: PMC4137047.
    38. Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov; 21(11):1370-6. PMID: 25126973.
      View in: PubMed
    39. Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58. PMID: 24917182; PMCID: PMC4148641.
    40. Cohen-Cline H, Wernli KJ, Bradford SC, Boles-Hall M, Grossman DC. Use of interactive voice response to improve colorectal cancer screening. Med Care. 2014 Jun; 52(6):496-9. PMID: 24638119.
      View in: PubMed
    41. Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7. PMID: 24793956; PMCID: PMC4082473.
    42. Johnson KE, Kamineni A, Fuller S, Olmstead D, Wernli KJ. How the provenance of electronic health record data matters for research: a case example using system mapping. EGEMS (Wash DC). 2014; 2(1):1058. PMID: 25821838.
      View in: PubMed
    43. Bowles EJ, Wernli KJ, Gray HJ, Bogart A, Delate T, O'Keeffe-Rosetti M, Nekhlyudov L, Loggers ET. Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003-2008: The Effect of the NCI Clinical Recommendation. Front Oncol. 2014; 4:43. PMID: 24653978; PMCID: PMC3948091.
    44. Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32. PMID: 24247555; PMCID: PMC3905972.
    45. Wernli KJ, O'Meara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, Sprague BL, Henderson LM, Buist DS. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014 Jan; 106(1):djt341. PMID: 24309005; PMCID: PMC3906993.
    46. Li W, Ray RM, Thomas DB, Yost M, Davis S, Breslow N, Gao DL, Fitzgibbons ED, Camp JE, Wong E, Wernli KJ, Checkoway H. Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol. 2013 Oct 01; 178(7):1038-45. PMID: 24043439; PMCID: PMC3783098.
    47. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67. PMID: 24037812; PMCID: PMC3935985.
    48. Wernli KJ, Kitahara CM, Tamers SL, Al-Temimi MH, Braithwaite D. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41. PMID: 23845714.
      View in: PubMed
    49. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16. PMID: 23552817; PMCID: PMC3699693.
    50. Wernli KJ, Inadomi JM. Anesthesia for colonoscopy: too much of a good thing? JAMA Intern Med. 2013 Apr 08; 173(7):556-8. PMID: 23479078.
      View in: PubMed
    51. Wernli KJ, Rutter CM, Dachman AH, Zafar HM. Suspected extracolonic neoplasms detected on CT colonography: literature review and possible outcomes. Acad Radiol. 2013 Jun; 20(6):667-74. PMID: 23465379.
      View in: PubMed
    52. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41. PMID: 23385442; PMCID: PMC3589257.
    53. Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA. Common single-nucleotide polymorphisms in the estrogen receptor ß promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res. 2013 Jan 15; 73(2):767-75. PMID: 23149914; PMCID: PMC3588850.
    54. Carlos RC, Buist DS, Wernli KJ, Swan JS. Patient-centered outcomes in imaging: quantifying value. J Am Coll Radiol. 2012 Oct; 9(10):725-8. PMID: 23025867.
      View in: PubMed
    55. Schur EA, Elmore JE, Onega T, Wernli KJ, Sickles EA, Haneuse S. The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev. 2012 Feb; 21(2):327-36. PMID: 22144503; PMCID: PMC3275693.
    56. Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer. 2011 Mar 01; 104(5):763-8. PMID: 21304527; PMCID: PMC3048198.
    57. Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DS. Timing of follow-up after abnormal screening and diagnostic mammograms. Am J Manag Care. 2011 Feb; 17(2):162-7. PMID: 21473665; PMCID: PMC3151253.
    58. Burnett-Hartman AN, Newcomb PA, Mandelson MT, Adams SV, Wernli KJ, Shadman M, Wurscher MA, Makar KW. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms. Nutr Cancer. 2011; 63(4):583-92. PMID: 21598178; PMCID: PMC3145495.
    59. Checkoway H, Ray RM, Lundin JI, Astrakianakis G, Seixas NS, Camp JE, Wernli KJ, Fitzgibbons ED, Li W, Feng Z, Gao DL, Thomas DB. Lung cancer and occupational exposures other than cotton dust and endotoxin among women textile workers in Shanghai, China. Occup Environ Med. 2011 Jun; 68(6):425-9. PMID: 21131604; PMCID: PMC3071898.
    60. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):131-7. PMID: 21254283; PMCID: PMC3074001.
    61. Braithwaite D, Wernli KJ, Anton-Culver H, Engstrom P, Greenberg ER, Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1665-7. PMID: 20615883.
      View in: PubMed
    62. Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res. 2010 Aug; 20(4):305-9. PMID: 20580999; PMCID: PMC2918710.
    63. Astrakianakis G, Seixas NS, Ray R, Camp JE, Gao DL, Feng Z, Li W, Wernli KJ, Fitzgibbons ED, Thomas DB, Checkoway H. Re: Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2010 Jun 16; 102(12):913-4. PMID: 20445162.
      View in: PubMed
    64. Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Camp JE, Heagerty PJ, De Roos AJ, Holt VL, Thomas DB, Checkoway H. Physical activity, physical exertion, and miscarriage risk in women textile workers in Shanghai, China. Am J Ind Med. 2010 May; 53(5):497-505. PMID: 20340112; PMCID: PMC2863132.
    65. Wernli KJ, Wang Y, Zheng Y, Potter JD, Newcomb PA. The relationship between gravidity and parity and colorectal cancer risk. J Womens Health (Larchmt). 2009 Jul; 18(7):995-1001. PMID: 19575687; PMCID: PMC2851134.
    66. Shadman M, Newcomb PA, Hampton JM, Wernli KJ, Trentham-Dietz A. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk. World J Gastroenterol. 2009 May 21; 15(19):2336-9. PMID: 19452574; PMCID: PMC2684598.
    67. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf. 2009 Apr; 18(4):284-90. PMID: 19226540; PMCID: PMC2720762.
    68. Wong EY, Ray RM, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Camp JE, Astrakianakis G, Heagerty PJ, De Roos AJ, Holt VL, Thomas DB, Checkoway H. Dust and chemical exposures, and miscarriage risk among women textile workers in Shanghai, China. Occup Environ Med. 2009 Mar; 66(3):161-8. PMID: 18805889; PMCID: PMC2862777.
    69. Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for endometrial cancer among textile workers in Shanghai, China. Am J Ind Med. 2008 Sep; 51(9):673-9. PMID: 18626909; PMCID: PMC2574926.
    70. Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Wernli KJ, Li W, Thomas DB. Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2009 Feb; 20(1):27-34. PMID: 18704712; PMCID: PMC2628413.
    71. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer. 2008 Jun 03; 98(11):1781-3. PMID: 18506182; PMCID: PMC2410126.
    72. Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Wong EY, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational exposures and ovarian cancer in textile workers. Epidemiology. 2008 Mar; 19(2):244-50. PMID: 18300714.
      View in: PubMed
    73. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control. 2008 Aug; 19(6):605-13. PMID: 18264784; PMCID: PMC2729759.
    74. Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Wernli KJ, Li W, Thomas DB. Monthly injectable contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Contraception. 2007 Jul; 76(1):40-4. PMID: 17586135.
      View in: PubMed
    75. Ray RM, Gao DL, Li W, Wernli KJ, Astrakianakis G, Seixas NS, Camp JE, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H. Occupational exposures and breast cancer among women textile workers in Shanghai. Epidemiology. 2007 May; 18(3):383-92. PMID: 17435449.
      View in: PubMed
    76. Astrakianakis G, Seixas NS, Ray R, Camp JE, Gao DL, Feng Z, Li W, Wernli KJ, Fitzgibbons ED, Thomas DB, Checkoway H. Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2007 Mar 07; 99(5):357-64. PMID: 17341727.
      View in: PubMed
    77. Rosenblatt KA, Gao DL, Ray RM, Rowland MR, Nelson ZC, Wernli KJ, Li W, Thomas DB. Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2006 Dec; 17(10):1275-80. PMID: 17111259.
      View in: PubMed
    78. Wernli KJ, Astrakianakis G, Camp JE, Ray RM, Chang CK, Li GD, Thomas DB, Checkoway H, Seixas NS. Development of a job exposure matrix (JEM) for the textile industry in Shanghai, China. J Occup Environ Hyg. 2006 Oct; 3(10):521-9. PMID: 16908453.
      View in: PubMed
    79. Wernli KJ, Ray RM, Gao DL, De Roos AJ, Checkoway H, Thomas DB. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control. 2006 Sep; 17(7):949-55. PMID: 16841262.
      View in: PubMed
    80. Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Camp JE, Ray RM, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Vaughan TL, Checkoway H. Risks of biliary tract cancer and occupational exposures among Shanghai women textile workers: a case-cohort study. Am J Ind Med. 2006 Aug; 49(8):690-8. PMID: 16830349.
      View in: PubMed
    81. Li W, Ray RM, Gao DL, Fitzgibbons ED, Seixas NS, Camp JE, Wernli KJ, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for pancreatic cancer among female textile workers in Shanghai, China. Occup Environ Med. 2006 Dec; 63(12):788-93. PMID: 16847032; PMCID: PMC2078009.
    82. Gold LS, De Roos AJ, Ray RM, Wernli K, Fitzgibbons ED, Gao DL, Astrakianakis G, Feng Z, Thomas D, Checkoway H. Brain tumors and occupational exposures in a cohort of female textile workers in Shanghai, China. Scand J Work Environ Health. 2006 Jun; 32(3):178-84. PMID: 16804619.
      View in: PubMed
    83. Wernli KJ, Fitzgibbons ED, Ray RM, Gao DL, Li W, Seixas NS, Camp JE, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for esophageal and stomach cancers among female textile workers in Shanghai, China. Am J Epidemiol. 2006 Apr 15; 163(8):717-25. PMID: 16467414.
      View in: PubMed
    84. Li W, Ray RM, Gao DL, Fitzgibbons ED, Seixas NS, Camp JE, Wernli KJ, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for nasopharyngeal cancer among female textile workers in Shanghai, China. Occup Environ Med. 2006 Jan; 63(1):39-44. PMID: 16361404; PMCID: PMC2078032.
    85. Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Ray RM, Gao DL, Wernli KJ, Fitzgibbons ED, Vaughan TL, Checkoway H. Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study. Int J Epidemiol. 2006 Apr; 35(2):361-9. PMID: 16373377.
      View in: PubMed
    86. De Roos AJ, Ray RM, Gao DL, Wernli KJ, Fitzgibbons ED, Ziding F, Astrakianakis G, Thomas DB, Checkoway H. Colorectal cancer incidence among female textile workers in Shanghai, China: a case-cohort analysis of occupational exposures. Cancer Causes Control. 2005 Dec; 16(10):1177-88. PMID: 16215868.
      View in: PubMed
    87. Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health. 2006 Mar; 79(3):251-8. PMID: 16220287.
      View in: PubMed
    88. Wernli KJ, Ray RM, Gao DL, Thomas DB, Checkoway H. Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989-1998. Am J Ind Med. 2003 Dec; 44(6):595-9. PMID: 14635236.
      View in: PubMed
    89. Camp JE, Seixas NS, Wernli K, Fitzgibbons D, Astrakianakis G, Thomas DB, Gao DL, Checkoway H. Development of a cancer research study in the Shanghai textile industry. Int J Occup Environ Health. 2003 Oct-Dec; 9(4):347-56. PMID: 14664489.
      View in: PubMed
    Wernli's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.